Semaglutide Injectable Product: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Semaglutide Injectable Product

• Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity
  NCT07136714 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
  NCT06423599 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
  NCT06706284 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
  NCT04174755 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Semaglutide Injectable Product?

4 recruiting trials across 11 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.